Picture of HH Biotechnology Holdings Co logo

HHBT HH Biotechnology Holdings Co Income Statement

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Annual income statement for HH Biotechnology Holdings Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2011
December 31st
2012
December 31st
2013
December 31st
2014
December 31st
2015
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue7.117.357.697.997.99
Cost of Revenue
Gross Profit0.9321.061.241.72.37
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses8.238.278.3510.84.89
Operating Profit-1.12-0.914-0.656-2.773.1
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1.86-2.33-1.81-4.312.66
Provision for Income Taxes
Net Income After Taxes3.19-2.33-1.81-4.312.42
Minority Interest
Net Income Before Extraordinary Items
Net Income3.19-2.33-1.81-4.312.48
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income3.19-2.33-1.81-4.312.48
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.213-0.238-0.166-0.3820.183
Dividends per Share